Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1972 3
1973 1
1975 2
1978 1
1982 2
1983 1
1984 2
1985 1
1986 1
1992 1
1993 1
1994 1
1998 1
2000 1
2001 1
2002 2
2005 1
2006 2
2008 1
2010 3
2011 2
2013 2
2015 3
2016 1
2018 1
2019 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Neuroacanthocytosis syndromes.
Jung HH, Danek A, Walker RH. Jung HH, et al. Orphanet J Rare Dis. 2011 Oct 25;6:68. doi: 10.1186/1750-1172-6-68. Orphanet J Rare Dis. 2011. PMID: 22027213 Free PMC article. Review.
NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'000 inhabitants for each disorder. The core NA syndromes include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome which have a Huntington's disease-l …
NA syndromes are exceptionally rare with an estimated prevalence of less than 1 to 5 per 1'000'000 inhabitants for each disord …
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
Bini S, Tramontano D, Minicocci I, Di Costanzo A, Tambaro F, D'Erasmo L, Arca M. Bini S, et al. Curr Atheroscler Rep. 2023 Jan;25(1):19-29. doi: 10.1007/s11883-022-01076-w. Epub 2023 Jan 6. Curr Atheroscler Rep. 2023. PMID: 36607583 Review.
RECENT FINDINGS: Recent trials have demonstrated the efficacy and safety of ANGPTL3 inhibition in treating homozygous familial hypercholesterolemia even in those patients carrying biallelic null/null variants, thus supporting the notion that the LDL-lowering effect of ANGP …
RECENT FINDINGS: Recent trials have demonstrated the efficacy and safety of ANGPTL3 inhibition in treating homozygous familial hyperc …
[Neuroacanthocytosis update].
Ichiba M, Nakamura M, Sano A. Ichiba M, et al. Brain Nerve. 2008 Jun;60(6):635-41. Brain Nerve. 2008. PMID: 18567359 Review. Japanese.
In the late 1960s, Levine et al. reported a family with a syndrome of neurological deficits such as choreiform involuntary movements, epileptic seizures, intellectual impairment, and paranoid ideation along with acanthocytosis without any disturbance in either alpha- or beta-lipo …
In the late 1960s, Levine et al. reported a family with a syndrome of neurological deficits such as choreiform involuntary movements, epilep …
Chylomicron retention disease: genetics, biochemistry, and clinical spectrum.
Levy E, Poinsot P, Spahis S. Levy E, et al. Curr Opin Lipidol. 2019 Apr;30(2):134-139. doi: 10.1097/MOL.0000000000000578. Curr Opin Lipidol. 2019. PMID: 30640893 Review.
Hypocholesterolemia could be accounted for by a decrease in HDL cholesterol, likely a reflection of limited production of intestinal HDL in view of reduced ATP-binding cassette family A protein 1 and apolipoprotein A-I protein. In experimental studies, the paralog SAR1A co …
Hypocholesterolemia could be accounted for by a decrease in HDL cholesterol, likely a reflection of limited production of intestinal HDL in …
Current Diagnosis and Management of Abetalipoproteinemia.
Takahashi M, Okazaki H, Ohashi K, Ogura M, Ishibashi S, Okazaki S, Hirayama S, Hori M, Matsuki K, Yokoyama S, Harada-Shiba M. Takahashi M, et al. J Atheroscler Thromb. 2021 Oct 1;28(10):1009-1019. doi: 10.5551/jat.RV17056. Epub 2021 May 16. J Atheroscler Thromb. 2021. PMID: 33994405 Free PMC article. Review.
Novel therapeutic modalities that improve quality of life and prognosis are awaited. The aim of this review is to 1) summarize the pathogenesis, clinical signs and symptoms, diagnosis, and management of ABL, and 2) propose diagnostic criteria that define eligibility to rec …
Novel therapeutic modalities that improve quality of life and prognosis are awaited. The aim of this review is to 1) summarize the pa …
Apolipoprotein disorders.
Assmann G, Menzel HJ. Assmann G, et al. Ric Clin Lab. 1982 Jan-Mar;12(1):63-81. doi: 10.1007/BF02909310. Ric Clin Lab. 1982. PMID: 6806887 Review. No abstract available.
[Homozygous familial hypobetalipoproteinemia caused by APOB gene variations: a case report and review of literature].
Zhang YQ, Wang JS. Zhang YQ, et al. Zhonghua Er Ke Za Zhi. 2023 Jan 2;61(1):70-75. doi: 10.3760/cma.j.cn112140-20220926-00838. Zhonghua Er Ke Za Zhi. 2023. PMID: 36594125 Review. Chinese.
The literature was searched from China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, China VIP database, China Biology Medicine disc and PubMed database (up to May 2022) with "familial hypobetalipoproteinemia" or "hypobetalipoprotein
The literature was searched from China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, China VIP database, China …
The malabsorption syndromes.
Gerrard JW, Lubos MC. Gerrard JW, et al. Pediatr Clin North Am. 1967 Feb;14(1):73-91. doi: 10.1016/s0031-3955(16)31944-7. Pediatr Clin North Am. 1967. PMID: 5334379 Review. No abstract available.
43 results